New mRNA Flu Vaccine Makes Us All Test Subjects

O

The New England Journal of Medicine released a study in May on a new mRNA flu vaccine. The author laughs at this innovation based on Covid shot technology. It raises questions about testing novel vaccines on the public like guinea pigs.

The study highlights a fresh approach to fighting seasonal flu with mRNA technology. This method, proven in Covid vaccines by Pfizer, aims to provide better protection. Yet the author sees humor in how quickly such shots move from lab to public use.

Many people worry about safety when new vaccines roll out fast. The piece pokes fun at the idea that everyone becomes part of a big experiment. It reminds readers to think twice before accepting every new medical product.

In the end, the story calls for caution with these advances. While vaccines help fight disease, rushing them without full checks can lead to problems. The laughter serves as a warning about blind trust in medical news.

Original Author: Alan Cassels | Source: Brownstone Institute

Comments